Silencing of phosphonate-gadolinium magnetic resonance imaging contrast by hydroxyapatite binding.
Alves FC, Donato P, Sherry AD, Zaheer A, Zhang S, Lubag AJ, Merritt ME, Lenkinski RE, Frangioni JV, Neves M, Prata MI, Santos AC, de Lima JJ, Geraldes CF.
Alves FC, et al. Among authors: geraldes cf.
Invest Radiol. 2003 Dec;38(12):750-60. doi: 10.1097/01.rli.0000084891.15996.0f.
Invest Radiol. 2003.
PMID: 14627892
Clinical Trial.